`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________________________
`
`INTERNATIONAL BUSINESS MACHINES CORP.,
`
`Petitioner
`
`v.
`
`INTELLECTUAL VENTURES II LLC
`
`Patent Owner.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case No. IPR2014-00587
`U.S. Patent 6,826,694
`
`
`
`
`
`Filed: October 30, 2014
`
`
`Filed on behalf of
`
`Patent Owner Intellectual Ventures II LLC
`By: Brenton R. Babcock
`
`Ted M. Cannon
`
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`
`2040 Main Street, Fourteenth Floor
`
`Irvine, CA 92614
`
`Tel.: (949) 760-0404
`
`Fax: (949) 760-9502
`
`Email:
`BoxPGL22@knobbe.com
`
`
`
`
`
`
`
`
`
`
`
`
`PATENT OWNER’S OPPOSITION TO PETITIONER’S MOTION TO
`LIMIT SCOPE OF CROSS-EXAMINATION OF
`DR. STEVEN M. BELLOVIN
`
`
`
`
`
`IPR2014-00587
`IBM v. Intellectual Ventures
`
`
`I. THE BOARD CONSIDERED AND REJECTED IBM’S IDENTICAL
`MOTION IN A CO-PENDING IPR BETWEEN THE PARTIES
`On May 15, 2014, IBM raised the identical issue of whether to limit cross-
`
`examination to the instituted grounds in a co-pending IPR between the same
`
`parties, and the panel denied IBM’s motion. IBM v. Intellectual Ventures II LLC,
`
`IPR2014-00180, Paper 13, at 2; Ex. 1026 at 23-24.
`
`This IPR
`1. Motion to Limit Scope of Cross-
`
`IPR2014-00180
`1. Motion to Limit Scope of Cross-
`
`Examination
`
`Examination
`
`IBM seeks authorization from
`
`the
`
`IBM seeks authorization from
`
`the
`
`Board to file a motion to limit IV’s
`
`Board to file a motion to limit IV’s
`
`crossexamination of IBM’s declarant,
`
`crossexamination of IBM’s declarant,
`
`Dr. Steven M. Bellovin,
`
`to
`
`the
`
`Dr. Çetin Kaya Koç,
`
`to
`
`the
`
`instituted
`
`ground
`
`of
`
`invalidity—
`
`instituted grounds of
`
`invalidity—
`
`contained in the Board’s Decision re
`
`contained in the Board’s Decision re
`
`Institution of Inter Partes Review
`
`Institution of Inter Partes Review
`
`(Paper 13)—based on the combination
`
`(Paper 10)—based on the combination
`
`of Hughes and Abraham.
`
`of Matsuzaki, Dworkin, Tenca, and the
`
`
`
`
`
`knowledge of one having ordinary skill
`
`in the art.
`
`- 1 -
`
`
`
`IPR2014-01516
`IBM v. Intellectual Ventures
`
`Alternatively, IBM requests the Board
`
`Alternatively, IBM requests the Board
`
`to provide guidance to the Parties on
`
`to provide guidance to the Parties on
`
`the
`
`appropriate
`
`scope of
`
`cross-
`
`the
`
`appropriate
`
`scope of
`
`cross-
`
`examination of Dr. Bellovin.
`
`examination of Dr. Koç.
`
`Status: Pending
`
`At a minimum, while this previous decision is not binding, candor counsels that
`
`Status: Denied
`
`this panel be informed of the previous decision and its underlying rationale.
`
`IBM’s motion actually cites to IPR2014-00180 for purported support, taking
`
`out of context the Board’s comment that “the cross-examination in our proceedings
`
`is typically limited to the grounds that we have instituted on.” Paper 22 at 3, citing
`
`IPR2014-00180, Ex. 1026 at 23:15-20. But when read in context, the Panel was
`
`not stating that the Board limits cross-examination beyond Rule 42.53(d)(5)(ii),
`
`but rather that cross-examiners typically focus their questioning on the instituted
`
`grounds. Indeed, in a well-reasoned decision, the Board denied IBM’s motion:
`
`As to whether the patent owner can ask questions concerning
`grounds that are not instituted, I will caution that the cross-
`examination in our proceedings is typically limited to the grounds that
`we have instituted on. That’s all the guidance that we can provide at
`this time as to whether questions of credibility may become relevant
`based on those redundant grounds. Those need to be addressed at
`the time the question is made.
`
`- 2 -
`
`
`
`IPR2014-01516
`IBM v. Intellectual Ventures
`
`
`In view, of course—the parties can, of course, deal with the
`objection and try to seek a compromise at that time. . . .
`So at this time, Motions 1 [to limit cross-examination] and 2
`are denied without prejudice, of course.
`IPR2014-00180, Ex. 1026 at 23:15-24:10 (emphasis added).
`
`Thus, by ignoring the Board’s previous decision, IBM is merely trying to get
`
`a second bite at the apple, seeking to create inconsistency in the Board’s precedent.
`
`II. CROSS-EXAMINATION IS GENERALLY PERMITTED ON THE
`ENTIRE SCOPE OF DIRECT TESTIMONY
`By rule, cross-examination is “limited to the scope of the direct testimony.”
`
`37 C.F.R. § 42.53(d)(5)(ii). No compelling reason exists here to further limit this
`
`scope, and several general decisions of the Board have not done so. See Micron
`
`Tech., Inc. v. Bd. of Trustees of the Univ. of Ill., IPR2013-00005, Paper 22 at 3;
`
`Intelligent Bio-Systems, Inc. v. Illumina Cambridge Ltd., IPR2013-00128, Paper 34
`
`at 5; Intelligent Bio-Systems, Inc. v. Illumina Cambridge Ltd., IPR2013-00266,
`
`Paper 27, at 3-4 (different patent at issue than IPR2013-00128); Kyocera Corp. v.
`
`Softview LLC, IPR2013-00007, Paper 18 at 4. For example, the panel in Micron
`
`declined to limit cross-examination beyond the rule, explaining that portions of
`
`expert testimony not related to the instituted grounds “may be relevant to the state
`
`of the prior art or the credibility of the most pertinent portions of the testimony.”
`
`IPR2013-00005, Paper 22 at 3. IV cited the Micron case during the October 16th
`
`conference call (Ex. 1024 at 15), but IBM’s motion ignores it. Similarly, in IBS,
`
`- 3 -
`
`
`
`IPR2014-01516
`IBM v. Intellectual Ventures
`
`the Board “decline[d] to further limit the cross-examination testimony beyond [the]
`
`limitation” in the rule, although not all grounds were instituted. IPR2013-00128,
`
`Paper 34 at 5. Kyocera likewise held that “Petitioner should make [declarant]
`
`available for cross-examination on all direct testimony” despite instituting only on
`
`some grounds. IPR2013-00007, Paper 18 at 4 (emphasis added); Paper 11 at 38.
`
`IBM’s motion suggests that there are several different decisions that support
`
`its position by citing to five IPRs; but these IPRs all relate to the same
`
`consolidated proceeding. Paper 22 at 2-3 (citing ZTE Corp. v. Contenguard
`
`Holdings, Inc., IPR2013-00136, Paper 27 at 3; IPR2013-00133, Paper 30 at 2-3;
`
`IPR2013-00137, Paper 33 at 2-3; IPR2013-00138, Paper 34 at 2-3; IPR2013-
`
`00139, Paper 32 at 2-3.). In particular, the parties in each of these IPRs agreed to
`
`consolidate depositions. See id. This agreement to consolidate depositions,
`
`presumably to avoid five days of cross-examination, was likely a factor considered
`
`by the Board in further limiting the scope of cross-examination. No such
`
`consolidation has been stipulated to in this proceeding. Thus, there is no reason to
`
`further limit cross-examination beyond the limits of Rule 42.53(d)(5)(ii).
`
`III. THE ENTIRE DECLARATION IS PART OF THE RECORD AND IS
`THEREFORE SUBJECT TO CROSS-EXAMINATION
`IBM mistakenly asserts that the declaration testimony and exhibits that IBM
`
`seeks to circumscribe are not part of the record, referring to IV’s objections and
`
`setting up IBM’s own straw man: “[I]f these paragraphs and exhibits are excluded,
`
`- 4 -
`
`
`
`IPR2014-01516
`IBM v. Intellectual Ventures
`
`they are not part of the direct testimony. Because they are not part of the direct
`
`testimony, IV cannot cross-examine Dr. Bellovin about them.” Paper 22 at 4
`
`(emphasis added). Yet no part of the Bellovin declaration or IBM exhibits have
`
`been excluded or expunged, nor has either party filed any motion to exclude. IBM
`
`has not even suggested that the Bellovin Declaration should be replaced by some
`
`form of a redacted declaration, or that certain exhibits should be expunged from
`
`the record, in whole or in part. Indeed, IV’s routine evidentiary objections merely
`
`preserve its right to potentially file a motion on Due Date 4 (April 29, 2015) to
`
`exclude evidence if IBM attempts to misuse that evidence in some manner.
`
`If the Board were to decide that certain portions of the Bellovin testimony
`
`and certain exhibits are not part of the record in this IPR, the Board would first
`
`need to identify that evidence and, presumably, expunge it. See 37 C.F.R. § 42.7.
`
`However, doing so would likely prove quite challenging because it would be
`
`difficult to pinpoint each and every paragraph of the declaration, and each and
`
`every exhibit, that solely corresponds to the non-instituted grounds. Moreover,
`
`such an order would set an incredibly burdensome precedent, making the Board
`
`responsible for parsing through every declaration paragraph (149 paragraphs in this
`
`case) and each exhibit to identify what evidence relates to which grounds,
`
`including any paragraphs that may relate to multiple grounds.
`
`Thus, IV requests that the Board not further limit Rule 42.53(d)(5)(ii).
`
`- 5 -
`
`
`
`IPR2014-01516
`IBM v. Intellectual Ventures
`
`
`
`
`
`
`Dated: October 30, 2014
`
`
`
`Respectfully submitted,
`
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`
`By:/Brenton R. Babcock/
`Brenton R. Babcock, Reg. No. 39,592
`Ted M. Cannon, Reg. No. 55,036
`Attorneys for Patent Owner
`Intellectual Ventures II LLC
`
`
`
`- 6 -
`
`
`
`IPR2014-00587
`IBM v. Intellectual Ventures
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that a true and correct copy of PATENT OWNER’S
`
`
`
`OPPOSITION TO PETITIONER’S MOTION TO LIMIT SCOPE OF
`
`CROSS-EXAMINATION OF DR. STEVEN M. BELLOVIN is being served on
`
`October 30, 2014, via electronic mail pursuant to 37 C.F.R. § 42.6(e) and with the
`
`agreement of counsel for Petitioners as addressed below:
`
`IBM_IPR_SERVICE@kirkland.com
`
`
`Kenneth R. Adamo
`kenneth.adamo@kirkland.com
`KIRKLAND & ELLIS LLP
`300 North LaSalle Street
`Chicago, Illinois 60654
`Telephone: (312) 862-2000
`Fax: (312) 862-2200
`
`Eugene Goryunov
`Eugene.goryunov@kirkland.com
`KIRKLAND & ELLIS LLP
`300 North LaSalle Street
`Chicago, Illinois 60654
`Telephone: (312) 862-2000
`Fax: (312) 862-2200
`
`
`
`
`Dated: October 30, 2014
`
`
`
`
`
`
`
`19156977
`
`
`/Brenton R. Babcock/
`Brenton R. Babcock, Reg. No. 39,592
`Ted M. Cannon, Reg. No. 55,036
`Attorneys for Patent Owner
`Intellectual Ventures II LLC
`
`
`
`- 7 -
`
`